About
Company
History
Certificates &
Intellectual properties
Investor relations
Newsroom
Location
Innovative science
Precision medicine platform
Big data platform
Artificial intelligence platform
Global network
Products
Introduction/ Business Area
Precision Medicine(HCC)
Precision medicine service for liver cancer
Prognostic & predictive test for liver cancer
Prognostic test for liver cancer
Predictive test for liver cancer
Biomarker
사업영역
사업화 현황
홈페이지이용안내
개인정보취급방침
이메일무단수집거부
KOR
About
Company
History
Certificates &
Intellectual properties
Investor relations
Newsroom
Location
Innovative science
Precision medicine platform
Big data platform
Artificial intelligence platform
Global network
Products
Introduction/ Business Area
Precision Medicine(HCC)
Precision medicine service for liver cancer
Prognostic & predictive test for liver cancer
Prognostic test for liver cancer
Predictive test for liver cancer
Biomarker
사업영역
사업화 현황
홈페이지이용안내
개인정보취급방침
이메일무단수집거부
Products
Products
About
Company
History
Certificates &
Intellectual properties
Investor relations
Newsroom
Location
Innovative science
Precision medicine platform
Big data platform
Artificial intelligence platform
Global network
Products
Introduction/ Business Area
Precision Medicine(HCC)
Precision medicine service for liver cancer
Prognostic & predictive test for liver cancer
Prognostic test for liver cancer
Predictive test for liver cancer
Biomarker
사업영역
사업화 현황
홈페이지이용안내
개인정보취급방침
이메일무단수집거부
Predictive test for liver cancer
About
Company
History
Certificates &
Intellectual properties
Investor relations
Newsroom
Location
Innovative science
Precision medicine platform
Big data platform
Artificial intelligence platform
Global network
Products
Introduction/ Business Area
Precision Medicine(HCC)
Precision medicine service for liver cancer
Prognostic & predictive test for liver cancer
Prognostic test for liver cancer
Predictive test for liver cancer
Biomarker
사업영역
사업화 현황
홈페이지이용안내
개인정보취급방침
이메일무단수집거부
Predictive test for liver cancer
About
Company
History
Certificates &
Intellectual properties
Investor relations
Newsroom
Location
Innovative science
Precision medicine platform
Big data platform
Artificial intelligence platform
Global network
Products
Introduction/ Business Area
Precision Medicine(HCC)
Precision medicine service for liver cancer
Prognostic & predictive test for liver cancer
Prognostic test for liver cancer
Predictive test for liver cancer
Biomarker
사업영역
사업화 현황
홈페이지이용안내
개인정보취급방침
이메일무단수집거부
Nexavar® companion diagnostic test for HCC
Nexavar® is a first line molecular-targeted agent in advanced hepatocellular carcinoma (HCC) treatment.
A clinically validated Nexavar® companion diagnostic test for HCC is able to improve the treatment outcome via patients stratification.
Drug : NEXAVAR® (Sorafenib)
Manufacturer : Bayer AG
Indication : HCC, RCC (advanced)
Patent expiration : 2020(US), 2021(EU)